Monday, May 6
8:00 am Short Course Registration and Morning Coffee
9:00 Pre-Conference Short Course (Click here for details)*
12:00 pm Conference Registration
Developing a Robust Alliance Management Strategy
Part 1: Integration and Culture
1:30 Chairperson's Opening RemarksFrances Toneguzzo, Ph.D., Executive Director, Research Ventures and Licensing, Partners HealthCare
1:45 Management, Transition and Integration of Strategic Alliances following Acquisitions
Doug Wilson, Pharm.D., Director, Alliance Management, GlaxoSmithKline
GlaxoSmithKline has performed some acquisitions over the last 10 years that have been varied in terms of their size and scope. We have attempted to learn from each experience and develop a process for assessing and integrating pipelines and alliances present in the acquired company. How this is done will depend in part on the structure and strategic intent of the acquisition. The presentation will describe the process (and associated learnings) used to assess, manage, transition and integrate the various alliance opportunities stemming from acquisitions.
2:15 Alliance Management Integration: Project Management
Lena Frank, CA-AM, PMP, Director, Alliance Management, Acorda Therapeutics
Establishing close relationships with, and utilizing the skills of project managers can make the job of managing alliance relationships so much easier. Have you maximized the capabilities of your project managers to help you ensure the success of your alliance? This presentation will explore the disciplines of alliance and project management, how the strength of each disciplined can be used to drive a successful alliance, what pitfalls to watch out for, and potential alliance and project management models.
2:45 Breaking Stereotypes: Managing Perceptions between Small and Large Commercial Alliance Partners
Andy Myslicki, PMP, Operations Director, Integrated Project Management
Entering an alliance with a preconceived opinion of your partner? Concerned with how they might perceive your company's level of sophistication or bureaucracy? Cultural differences can evoke feelings of uncertainty and mistrust, and increase susceptibility to forming stereotypes. These typecasts can be dispelled, however, with skilled program leaders who bring improved understanding, communication, collaboration, and impartiality. Using case studies from the perspectives of both sides of a Biotech-Pharma alliance, this presentation will share alliance management methodologies that prepare partnerships for success.Related Webinar: Mixing Project Management with Alliance Management: The Right Dose for Successful Clinical Trials with Integrated Project Management. Learn More
3:15 Refreshment Break in the Exhibit Hall
Part 2: Developing True Capability and Enhancing Value
Interactive Panel Discussion
3:45 Alliance Management Models across Diverse Biopharmaceutical Companies
Moderator: Lena Frank, Director, Alliance Management, Acorda Therapeutics
This panel is comprised of companies ranging from pre-sales biopharma to the large multinational pharmaceutical company and will include discussions on:
Mark Coflin, Executive Director, Business Development and Licensing, Alliance Management, Novartis Pharmaceuticals Corporation
Eric D. Malek, Vice President, Corporate Development, Threshold Pharmaceuticals, Inc.
Jose Ochoa, Vice President, Strategic Alliances & Business Development, Emergent Biosolutions, Inc.
Roland Ghanem, BSc, MBA, Executive Director, Alliance Management, Merck & Co., Inc.
4:45 Creating a True Organizational Capability in Alliance Management: Mapping the Journey, and Where We Go from Here
Stuart Kliman, J.D., Partner, Vantage Partners
Alliance Management, while not something which every organization has in place, is nevertheless now a well understood and embedded function in most major and mid-size life sciences firms. In this presentation, Stu Kliman will map the journey from concept to adding value capability, provide a set of reflections on where most organizations continue to have problematic gaps, and lay out a vision for how the function needs to grow over time to continue to innovate and meet the ever challenging needs of its organization's alliance dependent strategies.
The Evolution of Alliance Management:Perspective Over a Decade, Current Challenges, and Outlook
5:30 Welcome Reception in the Exhibit Hall (Sponsorship Opportunity Available)
250 First Avenue, Suite 300
Needham, MA 02494
Biological Therapeutic Products
Biomarkers & Diagnostics
Bioprocess & Manufacturing
Clinical Trials & Translational Medicine
Drug & Device Safety
Drug Discovery & Development
IT & Informatics
Technology & Tools For Life Science
Cambridge Healthtech Institute